Anellovirus protein encoded by <i>ORF2/3</i> functions as the viral replication initiation protein

N Nicole Boisvert (Ring Therapeutics) S Stephanie Thurmond (Ring Therapeutics) C Carmen Elenberger (Ring Therapeutics) P Patricio Jeraldo (Ring Therapeutics) C Cato Prince (Ring Therapeutics) N Nolan Sutherland (Ring Therapeutics) J José Melo (Ring Therapeutics) K Ken Tsheowang (Ring Therapeutics) C Cameron Dodier (Ring Therapeutics) M Maciej Nogalski (Ring Therapeutics) D Dinesh Verma (Ring Therapeutics) G Geoffrey Parsons (Ring Therapeutics) J Joseph Cabral (Ring Therapeutics)

Abstract

Anelloviridae is a family of single-stranded DNA viruses that are thought to be nonpathogenic and commensal. Despite their ubiquitous presence in human populations, little is known about the anellovirus mechanism of replication in host cells. We identified the protein coded by ORF2/3 as necessary and sufficient to initiate replication from the minimal origin of replication for viruses of both the Beta- and Alphatorquevirus genera. Supporting this observation, we identified components of the polymerase alpha and BTR (Bloom’s syndrome helicase (BLM), topoisomerase IIIα, RMI1, and RMI2) complexes as interacting with the viral replication initiation protein (Rip) during DNA replication, suggesting a recombination-dependent mechanism of replication that uses host cell machinery to mediate dissolution of replication intermediates. Furthermore, we mapped a 92-bp minimal origin of replication sequence for the Betatorquevirus genus composed of an adenine and thymine (AT)-rich stretch and a portion of the guanine and cytosine (GC)-rich region. Altogether, this study provides insight into the mechanism by which anelloviruses manipulate host cell machinery to facilitate viral genome replication and represents a significant step forward in understanding the complex processes underlying anellovirus replication and persistent infection of these important commensal viruses.

Article Details

Volume / Issue Vol. 122, Issue 52
Published December 30, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (13)

N

Nicole Boisvert

Ring Therapeutics

S

Stephanie Thurmond

Ring Therapeutics

C

Carmen Elenberger

Ring Therapeutics

P

Patricio Jeraldo

Ring Therapeutics

C

Cato Prince

Ring Therapeutics

N

Nolan Sutherland

Ring Therapeutics

J

José Melo

Ring Therapeutics

K

Ken Tsheowang

Ring Therapeutics

C

Cameron Dodier

Ring Therapeutics

M

Maciej Nogalski

Ring Therapeutics

D

Dinesh Verma

Ring Therapeutics

G

Geoffrey Parsons

Ring Therapeutics

J

Joseph Cabral

Ring Therapeutics